ABSTRACT Aim: To assess whether the use of direct real- time polymerase chain reaction (PCR) on smear-positive sputa can be cost-effective, by speciating mycobacteria earlier than current methods and thereby preventing unnecessary screening tests as part of the contact tracing process.
Methods: A retrospective study of all patients with smear-positive sputa in a Liverpool teach-ing hospital between 2004 and 2007. All the PCRs performed on these patients were re-viewed and compared them with their myco-bacterial culture results. Unit costs for PCR, chest X-ray (CXR), tuberculin skin test (TST), interferon-gamma (IFN-γ) and medical/nursing time were conservatively estimated at £50, £11, £10, £40 and £30 respectively. The total PCR costs were compared with the costs of unnec-essary follow up of patients, negative for My-cobacterium tuberculosis (MTB) by PCR, sub-sequently confirmed to be MTB culture nega-tive.
Results: 203 smear-positive patients under-went direct PCR testing. 126 (62%) patients grew Mycobacterium tuberculosis (MTB), 74 (37%) had environmental mycobacterial infection (EMI) and 3 (1%) were culture negative. Of the 126 patients’ culture positive MTB patients, 123 were PCR positive and 3 PCR negative. Of the 77 pa-tients that were culture negative for MTB, 75 were PCR negative and 2 PCR positive The sensitivity, specificity, positive and negative predictive values for direct PCR versus MTB culture were 98%, 96%, 98% and 97% respec-tively. Total costs of all PCRs performed amounted to £10,150. The cost of contact pro-cedures for PCR-negative and MTB culture- negative index cases was estimated at £19,650. This equated to a total saving of £9,500 in contact tracing costs.
Conclusions: Direct PCR examination testing of smear-positive patients can be cost-effective in areas where there is a high incidence of EMI.
Cite this paper
nullRenton, B. , Morrell, P. , Cooke, R. and Davies, P. (2009) Direct real-time PCR examination for Mycobacterium tuberculosis in respiratory samples can be cost effective. Health, 1, 63-66. doi: 10.4236/health.2009.12011.
 CG33 Tuberculosis – National Institute of Clinical Ex-cellent (NICE) guidelines. March 2006.
Corless, J.A., Stockton, P.A., Davies, P.D. (2000) Myco-bacterial culture results of smear-positive patients with suspected pulmonary tuberculosis in Britain. Eur Respir J, 16: 976-9.
National Collaborating Centre for Chronic Conditions: clinical diagnosis and management of tuberculosis and measures for its prevention and control. (2006). London, Royal College of Physicians.
Cramer, S.O., Matinmehr, F, Hillemann, D. (2004) Fast and sensitive detection of the Mycobacterium tuberculo-sis complex by real-time PCR, Clinical Microbiology and Infection, 10(3), 418.
Drobniewski, F.A., Watterson, S.A., Wilson, S.M., Harris, G.A. (2000) A clinical, microbiological and economic analysis of a national service for the rapid molecular di-agnosis of tuberculosis and rifampicin resistance in My-cobacterium tuberculosis. J Med Microbiol, 49:271-8.
Dowdy, D.W., Maters, A., Parrish, N., Beyrer, C., Dorman, S.E. (2003) Cost-effectiveness analysis of the Gen-Probe amplified Mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens. J Clin Microbiol, 41(3), 948-953.
van Cleeff, M., Kivihya-Ndugga, L., Githui, W., Ng’ang’a L., Kibuga, D., Odhiambo, J., et al. (2005) Cost-effectiveness of polymerase chain reaction versus Ziehl-Neelsen smear microscopy for diagnosis of tuber-culosis in Kenya. Int J Tuberc Lung Dis, 9:877-83.
Zalekis, R. (2005) Side-effects of Tuberculosis treatment. Breathe, 2(1), 69-73.
Piersimoni, C. and Scarparo, C. (2003) Minre-view–Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis com-plex in clinical samples. J Clin Microbiol, 41(12), 5355- 5365.
Taegtmeyer, M., Beeching, N.J., Scott, J., Seddon, K., Jamieson, S., Squire, S.B., Mwandumba, H.C., Miller, A.R.O., Davies, P.D.O., Parry, C.M. ( 2007) The Clinical impact of nucleic acid amplification tests on the diagno-sis and management of tuberculosis in a British hospital. Thorax Online.
Griffith, D.E., Aksamit, T., Barbara, A., et al. (2007) American thoracic society guidelines: Diagnosis, treat-ment and prevention of nontuberculous mycobacterial diseases. Am J Resp and Crit Care Med, 175, 367-417.